CrossAmerica
CAPL
21.54
0.00
0.00%
CrossAmerica
US · CAPL
#3400 by market cap
21.54
0.00
0.00%
Live - 5344 symbols - heartbeat 209s ago
· 2026-10-07 19:54
After-hours
21.54
0.00%
- Market cap
- 822.25M
- P/E (TTM)i
- 15.84
- P/Bi
- -7.67
- EPSi
- 1.02
- Div yieldi
- 9.75%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on CAPL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 46.76% -0.02pp
- Institutions
- 68 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Individual/Insider29.19%
Private Company23.14%
Mutual Fund21.17%
Public Company2.06%
Hedge Fund0.29%
Other24.05%
Top holders as of 2026-07-23
Joseph Topper
28.14% · 10.74M sh
Invesco Ltd.
14.98% · 5.72M sh
John B Reilly Jr Trust
13.02% · 4.97M sh
Dunne Manning Inc.
9.91% · 3.78M sh
ClearBridge Investments, LLC
1.63% · 623.75K sh
JPMorgan Chase & Co.
1.00% · 381.22K sh
Morgan Stanley Investment Management Inc.
0.97% · 369.41K sh
Raymond James Financial, Inc.
0.82% · 313.11K sh
First Trust Advisors L.P.
0.55% · 210.46K sh
Quadrant Private Wealth Management, LLC
0.43% · 163.36K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 35 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Joseph Topper | Chairman of CrossAmerica GP LLC | 28.14% |
| John B Reilly Jr Trust | -- | 13.02% |
| Charles Nifong | President, CEO & Director of CrossAmerica GP LLC | 0.24% |
| David Hrinak | Executive Vice President | 0.13% |
| Justin Gannon | Independent Director of CrossAmerica GP LLC | 0.10% |
| John Reilly | Vice Chairman of the Board of CrossAmerica GP LLC | 0.10% |
| Mickey Kim | Independent Director of CrossAmerica GP LLC | 0.09% |
| Keenan Lynch | General Counsel, Chief Administrative Officer & Director of CrossAmerica GP LLC | 0.08% |
| Maura Topper | CFO & Director of CrossAmerica GP LLC | 0.07% |
| Kenneth Valosky | Independent Director of CrossAmerica GP LLC | 0.07% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-22 | Thomas Kelso | Independent Director of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-22 | Joseph Topper | Chairman of CrossAmerica GP LLC | Other Derivative Acquisition | 0 | -- |
| 2026-07-22 | Joseph Topper | Chairman of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-22 | Mickey Kim | Independent Director of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-22 | Justin Gannon | Independent Director of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-22 | John Reilly | Vice Chairman of the Board of CrossAmerica GP LLC | Other Derivative Acquisition | 0 | -- |
| 2026-07-22 | John Reilly | Vice Chairman of the Board of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-22 | Kenneth Valosky | Independent Director of CrossAmerica GP LLC | Derivative Exercise and Retained | +3,154 | -- |
| 2026-07-20 | Thomas Kelso | Independent Director of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-07-20 | Joseph Topper | Chairman of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-07-20 | Mickey Kim | Independent Director of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-07-20 | Justin Gannon | Independent Director of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-07-20 | John Reilly | Vice Chairman of the Board of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-07-20 | Kenneth Valosky | Independent Director of CrossAmerica GP LLC | Other Derivative Acquisition | +3,040 | -- |
| 2026-05-20 | Joseph Topper | Chairman of CrossAmerica GP LLC | Other Acquisition | +6,373 | $22.72 |
| 2026-05-20 | Joseph Topper | Chairman of CrossAmerica GP LLC | Other Disposition | -6,373 | $22.72 |
| 2026-03-01 | Jonathan Benfield | Chief Accounting Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-02-23 | David Hrinak | Executive Vice President | Sale to Issuer | -624 | $20.78 |
| 2026-02-23 | David Hrinak | Executive Vice President | Other Acquisition | +1,832 | -- |
| 2026-02-23 | Stephen Lattig | Senior Vice President | Sale to Issuer | -491 | $20.78 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.